Cargando…

Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1

The long-chain fatty acid receptor FFAR1/GPR40 binds agonists in both an interhelical site between the extracellular segments of transmembrane helix (TM)-III and TM-IV and a lipid-exposed groove between the intracellular segments of these helices. Molecular dynamics simulations of FFAR1 with agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Lückmann, Michael, Trauelsen, Mette, Bentsen, Marie A., Nissen, Tinne A. D., Martins, Joao, Fallah, Zohreh, Nygaard, Mads M., Papaleo, Elena, Lindorff-Larsen, Kresten, Schwartz, Thue W., Frimurer, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452680/
https://www.ncbi.nlm.nih.gov/pubmed/30872479
http://dx.doi.org/10.1073/pnas.1811066116
_version_ 1783409332800454656
author Lückmann, Michael
Trauelsen, Mette
Bentsen, Marie A.
Nissen, Tinne A. D.
Martins, Joao
Fallah, Zohreh
Nygaard, Mads M.
Papaleo, Elena
Lindorff-Larsen, Kresten
Schwartz, Thue W.
Frimurer, Thomas M.
author_facet Lückmann, Michael
Trauelsen, Mette
Bentsen, Marie A.
Nissen, Tinne A. D.
Martins, Joao
Fallah, Zohreh
Nygaard, Mads M.
Papaleo, Elena
Lindorff-Larsen, Kresten
Schwartz, Thue W.
Frimurer, Thomas M.
author_sort Lückmann, Michael
collection PubMed
description The long-chain fatty acid receptor FFAR1/GPR40 binds agonists in both an interhelical site between the extracellular segments of transmembrane helix (TM)-III and TM-IV and a lipid-exposed groove between the intracellular segments of these helices. Molecular dynamics simulations of FFAR1 with agonist removed demonstrated a major rearrangement of the polar and charged anchor point residues for the carboxylic acid moiety of the agonist in the interhelical site, which was associated with closure of a neighboring, solvent-exposed pocket between the extracellular poles of TM-I, TM-II, and TM-VII. A synthetic compound designed to bind in this pocket, and thereby prevent its closure, was identified through structure-based virtual screening and shown to function both as an agonist and as an allosteric modulator of receptor activation. This discovery of an allosteric agonist for a previously unexploited, dynamic pocket in FFAR1 demonstrates both the power of including molecular dynamics in the drug discovery process and that this specific, clinically proven, but difficult, antidiabetes target can be addressed by chemotypes different from existing ligands.
format Online
Article
Text
id pubmed-6452680
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-64526802019-04-11 Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 Lückmann, Michael Trauelsen, Mette Bentsen, Marie A. Nissen, Tinne A. D. Martins, Joao Fallah, Zohreh Nygaard, Mads M. Papaleo, Elena Lindorff-Larsen, Kresten Schwartz, Thue W. Frimurer, Thomas M. Proc Natl Acad Sci U S A Biological Sciences The long-chain fatty acid receptor FFAR1/GPR40 binds agonists in both an interhelical site between the extracellular segments of transmembrane helix (TM)-III and TM-IV and a lipid-exposed groove between the intracellular segments of these helices. Molecular dynamics simulations of FFAR1 with agonist removed demonstrated a major rearrangement of the polar and charged anchor point residues for the carboxylic acid moiety of the agonist in the interhelical site, which was associated with closure of a neighboring, solvent-exposed pocket between the extracellular poles of TM-I, TM-II, and TM-VII. A synthetic compound designed to bind in this pocket, and thereby prevent its closure, was identified through structure-based virtual screening and shown to function both as an agonist and as an allosteric modulator of receptor activation. This discovery of an allosteric agonist for a previously unexploited, dynamic pocket in FFAR1 demonstrates both the power of including molecular dynamics in the drug discovery process and that this specific, clinically proven, but difficult, antidiabetes target can be addressed by chemotypes different from existing ligands. National Academy of Sciences 2019-04-02 2019-03-14 /pmc/articles/PMC6452680/ /pubmed/30872479 http://dx.doi.org/10.1073/pnas.1811066116 Text en Copyright © 2019 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/ This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Biological Sciences
Lückmann, Michael
Trauelsen, Mette
Bentsen, Marie A.
Nissen, Tinne A. D.
Martins, Joao
Fallah, Zohreh
Nygaard, Mads M.
Papaleo, Elena
Lindorff-Larsen, Kresten
Schwartz, Thue W.
Frimurer, Thomas M.
Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
title Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
title_full Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
title_fullStr Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
title_full_unstemmed Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
title_short Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
title_sort molecular dynamics-guided discovery of an ago-allosteric modulator for gpr40/ffar1
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452680/
https://www.ncbi.nlm.nih.gov/pubmed/30872479
http://dx.doi.org/10.1073/pnas.1811066116
work_keys_str_mv AT luckmannmichael moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT trauelsenmette moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT bentsenmariea moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT nissentinnead moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT martinsjoao moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT fallahzohreh moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT nygaardmadsm moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT papaleoelena moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT lindorfflarsenkresten moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT schwartzthuew moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1
AT frimurerthomasm moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1